<PAGE>
Exhibit 10.2
REGISTRATION AGENCY CONTRACT ON PRODUCTS
MED-ANGIN AND MED-BRONCHOL
CONTRACT NO.: BMP/ Klosterfrau 20050622a
PARTY A: MCM Klosterfrau Klosterfrau
GmbH(Hereinafter referred to as
"KLOSTERFRAU")
Address: Gereonsmithlengasse 1-11
D-50670 Koln; Germany
PARTY B: Beijing Med-Pharma Co., Ltd.
(Hereinafter referred
to as "MED-PHARM")
Address: Room 2001, Capital Mansion, 6,
Xinyuan South Road;
Chaoyang District,
Beijing 100004, China
WHEREAS:
- Party A intends
to register Med-angin and Med-bronchol in Chinese relevant
administrations so that the products can be marketed in China.
- Med-Pharm
provides professional agency services including registrations
and
clinical trials of medical products for foreign pharmaceutical
companies.
The company is able to assist Party A in applying for
registration of Products such as Med-angin and Med-bronchol in
China.
THEREFORE:
In order to register Products of Med-angin
and Med-bronchol in the State Food
and Drug Administration (SFDA) as soon as
possible, the two parties, after
friendly and serious negotiation, have
entered into the following agreement.
ARTICLE 1. NAME OF THE PROJECT AND
COOPERATIVE AIM
1.1 Name: Application for
registration of Products of Med-angin and
Med-bronchol in SFDA
1.2 Aim: Party A hereby appoints
party B as its consultant for the purpose of
assisting
Part A in obtaining "IMPORT DRUG LICENSE " for Products of
Med-angin
and Med-bronchol by the end of 2008.
ARTICLE 2. RIGHTS AND OBLIGATIONS OF PARTY
A
2.1 To offer "Power of Attorney
on Product Registrations" to Party B;
2.2 To preliminarily clear up
all technical materials and samples of the
registered
products and offer them to Party B as soon as possible
according
to "Materials on Import Biological Products Application" by
request of
SFDA;
2.3 To cooperate with Party B
actively and to offer required information
include
but not limited to supplementary documents, medicine packages
and
showpieces
of labels in respect of information and advice provided by
Party B
and the instructions of SFDA;
2.4 To pay on time for the
proceeding of the registration in order that
registrations
<PAGE>
can go
smoothly. The details are stipulated in appendix 1;
2.5 If SFDA requires visit and
examine KLOSTERFRAU manufacture in Germany, the
expenditure should be borne by Party A;
2.6 Party B should not be
responsible for the failure of the registrations if
party A
refuses to follow the provisions of SFDA and tests of product
quality
and clinical efficacy are not in accordance with the standards
and
requests
of SFDA;
ARTICLE 3. RIGHTS AND OBLIGATIONS OF PARTY
B
3.1 To start working upon
receiving the first payment;
3.2 To provide list of the
materials and documents required by registration
application to Party A and to approach the relevant evaluation
experts for
professional opinion or to organize "product registration
appraisal
meeting"
in time after receiving the above-mentioned materials so that
the
application can go smoothly;
3.3
